224 related articles for article (PubMed ID: 2190239)
21. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.
Davies SN; Martin D; Millar JD; Aram JA; Church J; Lodge D
Eur J Pharmacol; 1988 Jan; 145(2):141-51. PubMed ID: 2832187
[TBL] [Abstract][Full Text] [Related]
22. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.
Mansbach RS; Geyer MA
Neuropsychopharmacology; 1989 Dec; 2(4):299-308. PubMed ID: 2692589
[TBL] [Abstract][Full Text] [Related]
23. Dextromethorphan inhibits NMDA-induced convulsions.
Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
[TBL] [Abstract][Full Text] [Related]
24. Phencyclidine receptors and N-methyl-D-aspartate antagonism: electrophysiologic data correlates with known behaviours.
Martin D; Lodge D
Pharmacol Biochem Behav; 1988 Oct; 31(2):279-86. PubMed ID: 2854262
[TBL] [Abstract][Full Text] [Related]
25. N-methyl-D-aspartate (NMDA) receptors control respiratory off-switch in cat.
Foutz AS; Champagnat J; Denavit-Saubié M
Neurosci Lett; 1988 May; 87(3):221-6. PubMed ID: 2837690
[TBL] [Abstract][Full Text] [Related]
26. Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission.
Dimpfel W; Spüler M
Psychopharmacology (Berl); 1990; 101(3):317-23. PubMed ID: 2163537
[TBL] [Abstract][Full Text] [Related]
27. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
France CP; Woods JH; Ornstein P
Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release.
Snell LD; Yi SJ; Johnson KM
Eur J Pharmacol; 1988 Jan; 145(2):223-6. PubMed ID: 3280329
[TBL] [Abstract][Full Text] [Related]
29. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.
Koek W; Colpaert FC
J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
Ransom RW; Stec NL
Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pharmacodynamic effects of the non-competitive NMDA receptor antagonists MK-801 and ketamine in pigs.
Löscher W; Fredow G; Ganter M
Eur J Pharmacol; 1991 Jan; 192(3):377-82. PubMed ID: 1829039
[TBL] [Abstract][Full Text] [Related]
32. Mode of blockade by MK-801 of N-methyl-D-aspartate-induced increase in intracellular Ca2+ in cultured mouse hippocampal neurons.
Yuzaki M; Miyawaki A; Akita K; Kudo Y; Ogura A; Ino H; Mikoshiba K
Brain Res; 1990 May; 517(1-2):51-6. PubMed ID: 2165437
[TBL] [Abstract][Full Text] [Related]
33. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
Herberg LJ; Rose IC
Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
[TBL] [Abstract][Full Text] [Related]
34. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
Thompson LT; Disterhoft JF
J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
[TBL] [Abstract][Full Text] [Related]
35. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones.
MacDonald JF; Bartlett MC; Mody I; Pahapill P; Reynolds JN; Salter MW; Schneiderman JH; Pennefather PS
J Physiol; 1991 Jan; 432():483-508. PubMed ID: 1832184
[TBL] [Abstract][Full Text] [Related]
36. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
Willetts J; Balster RL
Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
[TBL] [Abstract][Full Text] [Related]
37. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage.
Clifford DB; Olney JW; Benz AM; Fuller TA; Zorumski CF
Epilepsia; 1990; 31(4):382-90. PubMed ID: 2196169
[TBL] [Abstract][Full Text] [Related]
38. Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits.
Hevers W; Hadley SH; Lüddens H; Amin J
J Neurosci; 2008 May; 28(20):5383-93. PubMed ID: 18480294
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
Nevins ME; Arnolde SM
Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
[TBL] [Abstract][Full Text] [Related]
40. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
Jackson A; Sanger DJ
Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
